JPRN-UMIN000014967已完成2 期
A randomized, placebo-controlled double-blind, study evaluating the effect of pirfenidone in patients with chronic kidney disease and diabetes mellitus - Effect of pirfenidone on kidney function in patients with diabetic renal disease
Meiyo Clinic, Hemodialysis Center0 个研究点目标入组 60 人开始时间: 2014年8月27日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Items prohibited in pirfenidone package insert 2)History of allergy to lactose used as placebo 3)Investigator concludes that the patient's participation in this study is inappropriate
研究者
相似试验
进行中（未招募）
不适用
A randomized, placebo-controlled, double-blind study on the intensity and duration of efficacy of sodium hyaluronate therapy (500-730 KDa) (HYALGAN) in the conservative treatment of Achilles tendinopathy. - NDEUCTR2010-020513-87-ITFIDIA
进行中（未招募）
1 期
A study to evaluate safety and efficacy of APO-2 at three different doses in patients with diabetic foot ulcerMedDRA version: 24.0Level: LLTClassification code 10012664Term: Diabetic foot ulcerSystem Organ Class: 100000004858Diabetic Foot UlcerEUCTR2018-001653-27-CZAposcience AG120
进行中（未招募）
1 期
Study to assess the safety and efficacy of PCN-101 in treatment-resistant depressioMedDRA version: 20.0Level: PTClassification code 10012378Term: DepressionSystem Organ Class: 10037175 - Psychiatric disordersTreatment-resistant depressionEUCTR2020-005457-25-PLPerception Neuroscience, Inc93
进行中（未招募）
1 期
A study to evaluate safety and efficacy of APO-2 at three different doses in patients with diabetic foot ulcerDiabetic Foot UlcerEUCTR2018-001653-27-DEAposcience AG132
进行中（未招募）
1 期
Investigation of efficacy of Secukinumab in patients with moderate to serve atopic dermatitisModerate to serve atopic dermatitisMedDRA version: 21.1Level: LLTClassification code 10003639Term: Atopic dermatitisSystem Organ Class: 100000004858EUCTR2016-005181-57-DEGWT-TUD GmbH45